World's Best Scientists 2026 revealed!
Claudio Rapezzi

Claudio Rapezzi

D-Index & Metrics

Medicine

D-Index
94
Citations
49991
World Ranking
10264
National Ranking
364

Claudio Rapezzi publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Claudio Rapezzi sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 625 publications — 74th percentile

74% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Claudio Rapezzi D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Claudio Rapezzi sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 94 D-Index — 49th percentile

49% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Claudio Rapezzi is affiliated with the University of Ferrara in Italy and has a substantial publication record spanning multiple domains within medicine and molecular biology. Their research contributions focus notably on cardiology and cardiovascular medicine, amassing expertise through numerous studies and reviews.

The scientist's recent papers include:

  • Diagnosis and treatment of cardiac amyloidosis: a position statement of the ESC Working Group on Myocardial and Pericardial Diseases, 2021, European Heart Journal
  • Diagnosis and treatment of cardiac amyloidosis. A position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases, 2021, European Journal of Heart Failure
  • ASNC/AHA/ASE/EANM/HFSA/ISA/SCMR/SNMMI Expert Consensus Recommendations for Multimodality Imaging in Cardiac Amyloidosis: Part 1 of 2-Evidence Base and Standardized Methods of Imaging, 2021, Circulation Cardiovascular Imaging
  • COVID-19 in the heart and the lungs: could we "Notch" the inflammatory storm?, 2020, Basic Research in Cardiology
  • Redefining the epidemiology of cardiac amyloidosis. A systematic review and meta-analysis of screening studies, 2022, European Journal of Heart Failure

Frequent co-authors collaborating with Claudio Rapezzi include:

  • Roberto Ferrari
  • Alberto Aimo
  • Michele Emdin
  • Gianfranco Sinagra
  • Giuseppe Vergaro

Their work appears regularly in the following publication venues:

  • European Heart Journal
  • European Journal of Heart Failure
  • European Heart Journal Supplements
  • PubMed
  • International Journal of Cardiology

Claudio Rapezzi's research spans many fields of study, predominantly:

  • Medicine
  • Biochemistry, Genetics and Molecular Biology

Within these fields, the subfields of study include:

  • Cardiology and Cardiovascular Medicine
  • Molecular Biology
  • Nephrology
  • Oncology
  • Infectious Diseases

Key research topics covered by Claudio Rapezzi are:

  • Amyloidosis: Diagnosis, Treatment, Outcomes
  • Parathyroid Disorders and Treatments
  • Cardiomyopathy and Myosin Studies
  • Cardiovascular Function and Risk Factors
  • Peptidase Inhibition and Analysis
  • Cardiac electrophysiology and arrhythmias
  • COVID-19 Clinical Research Studies

In addition to journal articles, Claudio Rapezzi has contributed to book publications, including the work published by Frontiers Media in 2023 titled Proceedings and Predictions in Cardiac Amyloidosis: Unsolved mysteries and challenges for the future.

Best Publications

  • 2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy The Task Force for the Diagnosis and Management of Hypertrophic Cardiomyopathy of the European Society of Cardiology (ESC)

    Perry M Elliott;Aris Anastasakis

  • Classification of the cardiomyopathies: a position statement from the european society of cardiology working group on myocardial and pericardial diseases

    Perry Elliott;Bert Andersson;Eloisa Arbustini;Zofia Bilinska

  • 2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy

    Perry M. Elliott;Aris Anastasakis;Michael A. Borger;Martin Borggrefe

  • Tafamidis Treatment for Patients with Transthyretin Amyloid Cardiomyopathy

    Mathew S. Maurer;Jeffrey H. Schwartz;Balarama Gundapaneni;Perry M. Elliott

  • Nonbiopsy Diagnosis of Cardiac Transthyretin Amyloidosis.

    Julian D. Gillmore;Mathew S. Maurer;Rodney H. Falk;Giampaolo Merlini

  • A novel clinical risk prediction model for sudden cardiac death in hypertrophic cardiomyopathy (HCM Risk-SCD)

    Constantinos O'Mahony;Fatima Jichi;Menelaos Pavlou;Lorenzo Monserrat

  • Prognostic Value of Quantitative Contrast-Enhanced Cardiovascular Magnetic Resonance for the Evaluation of Sudden Death Risk in Patients With Hypertrophic Cardiomyopathy

    Raymond H. Chan;Barry J. Maron;Iacopo Olivotto;Michael J. Pencina

  • Guidelines for the diagnosis and treatment of non-ST-segment elevation acute coronary syndromes The Task Force for the Diagnosis and Treatment of Non-ST-Segment Elevation Acute Coronary Syndromes of the European Society of Cardiology

    Claudio Rapezzi;Elena Biagini;Angelo Branzi

  • Noninvasive Etiologic Diagnosis of Cardiac Amyloidosis Using 99mTc-3,3-Diphosphono-1,2-Propanodicarboxylic Acid Scintigraphy

    Enrica Perugini;Pier Luigi Guidalotti;Fabrizio Salvi;Robin M.T. Cooke

  • Systemic Cardiac Amyloidoses Disease Profiles and Clinical Courses of the 3 Main Types

    Claudio Rapezzi;Giampaolo Merlini;Candida C. Quarta;Letizia Riva

  • Guideline of transthyretin-related hereditary amyloidosis for clinicians

    Yukio Ando;Teresa Coelho;John L. Berk;Márcia Waddington Cruz

  • Diagnosis and treatment of cardiac amyloidosis: a position statement of the ESC Working Group on Myocardial and Pericardial Diseases

    Pablo Garcia-Pavia;Claudio Rapezzi;Yehuda Adler;Michael Arad

  • ASNC/AHA/ASE/EANM/HFSA/ISA/SCMR/SNMMI Expert Consensus Recommendations for Multimodality Imaging in Cardiac Amyloidosis: Part 1 of 2—Evidence Base and Standardized Methods of Imaging

    Sharmila Dorbala;Yukio Ando;Sabahat Bokhari;Angela Dispenzieri

  • Genetic counselling and testing in cardiomyopathies: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases

    Philippe Charron;Michael Arad;Michael Arad;Eloisa Arbustini;Cristina Basso

  • Long-term safety of drug-eluting and bare-metal stents: Evidence from a comprehensive network meta-analysis

    Tullio Palmerini;Umberto Benedetto;Giuseppe Biondi-Zoccai;Diego Della Riva

  • Mortality in patients treated with extended duration dual antiplatelet therapy after drug-eluting stent implantation: a pairwise and Bayesian network meta-analysis of randomised trials

    Tullio Palmerini;Umberto Benedetto;Letizia Bacchi-Reggiani;Diego Della Riva

  • Genotype and Phenotype of Transthyretin Cardiac Amyloidosis: THAOS (Transthyretin Amyloid Outcome Survey).

    Mathew S. Maurer;Mazen Hanna;Martha Grogan;Angela Dispenzieri

  • Diagnostic work-up in cardiomyopathies: bridging the gap between clinical phenotypes and final diagnosis. A position statement from the ESC Working Group on Myocardial and Pericardial Diseases

    Claudio Rapezzi;Eloisa Arbustini;Alida L P Caforio;Philippe Charron

  • Addressing Common Questions Encountered in the Diagnosis and Management of Cardiac Amyloidosis

    Mathew S. Maurer;Perry Elliott;Raymond Comenzo;Marc Semigran

  • Long-term outcome and risk stratification in dilated cardiolaminopathies.

    Michele Pasotti;Catherine Klersy;Andrea Pilotto;Nicola Marziliano

Frequent Co-Authors

Angelo Branzi
Angelo Branzi University of Bologna
Giuseppe Boriani
Giuseppe Boriani University of Modena and Reggio Emilia
Giampaolo Merlini
Giampaolo Merlini University of Pavia
Mathew S. Maurer
Mathew S. Maurer Columbia University
Roberto Ferrari
Roberto Ferrari University of Ferrara
Gianfranco Sinagra
Gianfranco Sinagra University of Trieste
Perry M. Elliott
Perry M. Elliott University College London
Luigi Tavazzi
Luigi Tavazzi University of Ferrara
Eloisa Arbustini
Eloisa Arbustini Policlinico San Matteo Fondazione
Iacopo Olivotto
Iacopo Olivotto University of Florence

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring a career in Medicine opens the door to numerous related online degrees that can help you enter or advance in the healthcare field quickly and flexibly. Many students seek easy dnp programs for a less strenuous path to a Doctor of Nursing Practice, helping bridge the gap between academic achievement and clinical leadership roles.

For those wanting to start their medical career sooner, lpn program options offer a fast route to become a Licensed Practical Nurse, with online study that fits around your schedule. If you’re interested in mental health, consider enrolling in fast track mental health nursing programs that prepare you for rewarding roles supporting patients’ psychiatric needs.

Beyond clinical care, administrative roles are in high demand. Earning a health administration degree online equips you for leadership positions in medical facilities, with an emphasis on affordable, flexible study. Together, these options complement traditional medicine pathways, offering rewarding alternatives that let you shape your unique healthcare career.

Best Scientists Citing Claudio Rapezzi

Trending Scientists

Recently Published Articles